perioperative management of glp-1 agonists How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Patients on Glucagon-Like Perioperative Management of GLP-1 Receptor

Here, we review the current knowledge of CoQ 10 biosynthesis and primary CoQ 10 deficiency syndrome, and have collected published results from clinical trials based on CoQ 10 supplementation

And this is important both in terms of thinking about what effects you're going to get of taking a given peptide, if you decide to do that, as well as potential side effects, as well as things like how to adjust dosage and how long to take a peptide, whether or not to cycle the peptide, et cetera

The alternating hypothesis suggests that cycling between a pure GLP-1 agonist and a dual GIP/GLP-1 agonist could prevent or delay this tolerance

they are often primary effects that are just as pronounced as the tanning